News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Rashida Salahuddin

Advertisement

President and CEO, The Corporate Citizenship Project

Articles by Rashida Salahuddin

Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG Requirements

ByRashida Salahuddin
May 3rd 2022

Rise in demand for sustainable practices forces industry to be more proactive.

Advertisement

Latest Updated Articles

  • Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG Requirements
    Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG Requirements

    Published: May 3rd 2022 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Sanofi Reaches Deals with ADEL for Novel Alzheimer’s Disease Drug, Dren Bio for B-cell Depletion Therapy

2

FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma

3

FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer

4

Brent Saunders: Eyeing New Horizons

5

FDA Approves Lerochol for Adults with Elevated LDL Cholesterol

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us